CTT Pharmaceutical Holdings, Inc.

Equities

CTTH

US12651E1064

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:31:42 2024-05-17 EDT			5-day change	1st Jan Change
0.03 ^USD	-14.29%		-11.76%	+7.14%

2020	CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech	CI
2020	CTT Pharmaceutical Holdings, Inc. Announces Management Appointments	CI

CTT Pharma Corporate Update

May 25, 2022 at 09:31 am

(via TheNewswire)

Tampa, Florida, United States – TheNewswire – May 25, 2022 – CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is announcing today that Robert Allen has stepped down as a Board of Director. CTT Pharma appreciates the insight Mr. Allen gave and the time that he spent helping the company.

CTT Pharma is currently searching for Board Members that have extensive knowledge in the Nicotine Industry, as CTT is continuing to move forward into this space. Management will continue to update shareholders as more information becomes available.

Ryan Khouri - 813-606-0060

www.linkedin.com/in/ryan-khouri-679a251b7

www.cttpharmaceuticals.com

Latest news about CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc Enters into Business Development Partnership with 3 Rivers Biotech	20-09-08	CI
CTT Pharmaceutical Holdings, Inc. Announces Management Appointments	20-09-01	CI
CTT Pharmaceutical Holdings, Inc. Provides Update on the Successful Commercial Introduction of its Sublingual Strips with Aurora Cannabis	19-12-23	CI
CTT Pharmaceutical Holdings, Inc. Announces Management Changes	19-11-27	CI
Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers	19-10-08	CI
Rapid Dose Therapeutics Inc. cancelled the acquisition of certain assets of CTT Pharmaceutical Holdings, Inc..	18-10-30	CI
CTT Pharmaceutical Holdings, Inc. Appoints Jason Dyck to Board of Directors	18-07-12	CI
CTT Pharmaceuticals Announces Executive Management Change	18-06-07	CI
CTT Pharmaceutical Holdings, Inc. announced that it has received $1 million in funding from Aurora Cannabis Inc.	18-06-04	CI
CTT Pharmaceutical Holdings, Inc. announced that it expects to receive $1 million in funding from Aurora Cannabis Inc.	18-05-21	CI
Aurora Cannabis Gains Exclusive License to Novel Patented Sub-Lingual Wafer Technology from CTT Pharmaceutical	18-04-16	CI
Rapid Dose Therapeutics Inc. signed a letter of intent to acquire certain assets of CTT Pharmaceutical Holdings, Inc..	17-05-16	CI
CTT Pharmaceutical Holdings and CanniMed Therapeutics Complete Exclusive Canadian Licensing Agreement	17-02-17	CI
CanniMed Ltd. Enters into Letter of Intent with CTT Pharmaceutical Holdings Inc. to License CTT's Orally Dissolvable Thin Film Wafer Technology	16-08-23	CI
CTT Pharmaceutical Holdings, Inc. Announces Resignation of Lucie Letellier as Chief Financial Officer	16-02-11	CI
CTT Pharmaceutical Holdings, Inc. will Change its Ticker to CTTH from MDST.D	15-09-25	CI
Mindesta, Inc. will Change its Name to CTT Pharmaceutical Holdings, Inc	15-08-28	CI
Mindesta Inc. Announces Executive Changes	15-06-16	CI
Mindesta Inc. Auditor Raises 'Going Concern' Doubt	15-04-13	CI
Dr. Stephen Houldsworth, Pharma Manufacturing Expert, Joins CTT Pharmaceuticals Advisory Board	15-01-29	CI
Mindesta, Inc. Announces Executive Changes	15-01-01	CI
CTT Pharmaceuticals Announces Appointment of Michelle Hamilton Page as to the Advisory Board	14-11-26	CI
Mindesta, Inc Appoints Graham Wong to Vice President, Marketing	14-11-22	CI
CTT Pharmaceuticals Appoints Lucie Letellier as CFO	14-11-06	CI
Mindesta Inc. Announces Executive Appointments	14-10-01	CI

Chart CTT Pharmaceutical Holdings, Inc.

Duration

Period

More charts

Company Profile

CTT Pharmaceutical Holdings, Inc. is a development stage company. The Company is specialized in drug delivery systems technology within the pharmaceutical industry. The Company is focused is on fast dissolving drug delivery systems through the development of advanced oral delivery thin wafers. The Company plans to specialize in the development of oral drug delivery systems for pain management and treatment. Film strip encapsulated with the actives to help in pain reduction can include many combinations to help reduce pain and addiction and help patient safely. Oral Thin strips helps in pain management and inflammation indications, such as Arthritis. The Company has invented an ideal intra oral, fast-dissolving drug delivery system. This novel intraoral drug delivery system is its proprietary patented technology and is a thin, flexible and quick-dissolving film.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
CTT PHARMACEUTICAL HOLDINGS, INC.	+7.14%	1.79M
MODERNA, INC.	+33.63%	50.85B
IQVIA HOLDINGS INC.	-0.09%	42.82B
LONZA GROUP AG	+49.62%	42.03B
CELLTRION, INC.	-4.96%	29.55B
ICON PUBLIC LIMITED COMPANY	+11.18%	26.11B
ALNYLAM PHARMACEUTICALS, INC.	-21.95%	19.13B
BIO-TECHNE CORPORATION	+8.61%	13.05B
MEDPACE HOLDINGS, INC.	+28.31%	12.16B
UNITED THERAPEUTICS CORPORATION	+24.73%	12.08B

Other Biotechnology & Medical Research